Human Immune Response Genes

  • Gerald T. Nepom
  • John A. Hansen


The generation of an immune response is a complex process requiring multiple interactions and cellular events. The genetic elements participating in immune recognition and response appear to serve as permissive signals, the “green lights” of the immune network. Their interaction provides the basis for coordinated immune function. We summarize here recent information on the nature of these inherited elements and discuss the implications of these findings for genetically determined disease susceptibility.


Major Histocompatibility Complex Human Leukocyte Antigen Human Leukocyte Antigen Class Human Leukocyte Antigen Antigen Streptococcal Cell Wall 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albertini, R. J., and Bach, F. H., 1968, Quantitative assay of antigenic disparity of HLA—the major histocompatibility locus in man, J. Exp. Med. 128: 639–651.PubMedCrossRefGoogle Scholar
  2. Allison, J. P., Walker, L. E., Russell, W. A., Pellegrino, M. A., Ferrone, S., Reisfield, R. A., Frelinger, J. A., and Silver, J., 1978, Murine la and human DR antigens: Homology of amino-terminal sequences, Proc. Natl. Acad. Sci. U.S.A. 74: 5135–5139.Google Scholar
  3. Amos, D. B., and Bach, F. H., 1968, Phenotypic expressions of the major histocompatibility locus in man (HLA): Leukocyte antigens and mixed leukocyte culture reactivity, J. Exp. Med. 128: 623–637.PubMedCrossRefGoogle Scholar
  4. Andrews, D. W., Bono, M. R., and Strominger, J. L., 1982, A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing, Biochemistry 21: 6625–6628.PubMedCrossRefGoogle Scholar
  5. Bach, F. H., and Hirschhorn, K., 1964, Lymphocyte interaction: A potential histocompatibility test in vitro, Science 143: 813–814.PubMedCrossRefGoogle Scholar
  6. Bain, B., and Lowenstein, L., 1964, Genetic studies on the mixed leukocyte reaction, Science 145: 1315–1316.PubMedCrossRefGoogle Scholar
  7. Baldwin, G. C., Mickelson, E., Hansen, J. A., Nisperos, B., Antonelli, P., Nepom, B. S., and Nepom, G. T., 1985, Electrophoretic variation between class II molecules expressed on HLA-DRw homozygous typing cells reveals multiple distinct haplotypes, Immunogenetics 31: 49–60.CrossRefGoogle Scholar
  8. Ball, E. J., and Stastney, P., 1984, Antigen-specific HLA-restricted human T-cell lines, Immunogenetics 19: 13–26.PubMedCrossRefGoogle Scholar
  9. Beck, B. N., Frelinger, J. G., Shigeta, M., Infante, A. J., Cummings, D., Hammerling, G., and Fathman, C. G., 1982, T cell clones specific for hybrid 1-A molecules, J. Exp. Med. 156: 1186–1194.PubMedCrossRefGoogle Scholar
  10. Benacerraf, B., 1981, Role of MHC gene products in immune regulation, Science 212: 1229–1238.PubMedCrossRefGoogle Scholar
  11. Benacerraf, B., and Burakoff, S. J., 1978, The biological significance of alloreactivity, in: Genetic Control of Autoimmune Disease ( N. Rose, E. Bigazzi, and N. Warner, eds.), Elsevier, Amsterdam, pp. 321–326.Google Scholar
  12. Berle, E., and Thorsby, E., 1982, Both DR and MT Class II HLA molecules may restrict proliferative T- lymphocyte responses to antigen, Scand. J. Immunol. 16: 543–547.PubMedCrossRefGoogle Scholar
  13. Bodmer, J., and Bodmer, W., 1984, Histocompatibility, Immunol. Today 5: 251–254.CrossRefGoogle Scholar
  14. Bohme, J., Owerback, D., Denaro, M., Lernmark, A., Peterson, P. A., and Rask, L., 1983, Human class II major histocompatibility antigen β chains are derived from at least three loci, Nature 301: 82–84.PubMedCrossRefGoogle Scholar
  15. Bono, M. R., and Strominger, J. L., 1982, Direct evidence of homology between human DC-1 antigen and murine 1-A molecules, Nature 299: 836–838.PubMedCrossRefGoogle Scholar
  16. Corte, G., Calabi, F., Damiani, G., Bargellesi, A., Tosi, R., and Sorrentino, R., 1981, Human la molecules carrying DC1 determinants differ in both α- and β-subunits from la molecules carrying DR determinants, Nature 292: 357–360.PubMedCrossRefGoogle Scholar
  17. Dausset, J., 1954, Leuco-agglutinins. IV. Leuco-agglutinins and blood transfusion, Vox Sang. 4: 190–198.Google Scholar
  18. Dausset, J., 1981, The major histocompatibility complex in man, Science 213: 1469–1474.PubMedCrossRefGoogle Scholar
  19. Dausset, J., and Nenna, A., 1952, Presence d’une leuco-agglutinine dans le serum d’un cas d’agranulocytose chronique, C. R. Soc. Biol. (Paris) 146: 1539–1541.Google Scholar
  20. Day, C. E., and Jones, P. O., 1983, The gene encoding the la antigen-associated invariant chain (II) is not linked to the H-2 complex, Nature 302: 157–159.PubMedCrossRefGoogle Scholar
  21. de Kretser, T. A., Crumpton, M. J., Bodmer, J., and Bodmer, W. F., 1982, Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1, 2, w6 monoclonal antibody: Evidence for a third locus, Eur. J. Immunol. 12: 600–606.PubMedCrossRefGoogle Scholar
  22. Dorf, M. E., 1981, Genetic control of immune responsiveness, in: The Role of the Major Histocompatibility Complex in Immunobiology ( M. E. Dorf, ed.), Garland, New York, pp. 221–254.Google Scholar
  23. Eckels, D., Lake, P., Lamb, J., Johnson, A., Shaw, S., Woody, J., and Hartzkan, R., 1983, SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones, Nature 301: 716–718.PubMedCrossRefGoogle Scholar
  24. Eijsvoogel, V. P., Schellekens, P. T. A., Breur-Vriesendorp, B., van Leeuwen, A., Koch, C., and van Rood, J. J., 1970, HLA identity and one allelic differences in families and unrelated individuals, in: Histocompatibility Testing 1970 ( P. I. Terasaki, ed.), Munksgaard, Copenhagen, pp. 523–529.Google Scholar
  25. Fathman, C. G., Kimoto, M., Melvold, R., and David, C., 1981, Reconstitution of Ir genes, la antigens, and mixed lymphocyte reaction determinants by gene complementation, Proc. Natl. Acad. Sci. U.S.A. 78: 1853–1857.PubMedCrossRefGoogle Scholar
  26. Fuggle, S., Kirkley, J., Ting, A., and Morris, P. J., 1983, A monoclonal antibody recognizing HLA-DR2 on malignant and activated cells, Immunogenetics 18: 415–428.PubMedCrossRefGoogle Scholar
  27. Fuller, T. C., Einarson, M., Pinto, C., Ahern, A., and Yunis, E. J., 1978, Genetic evidence that HLA-DR (la) specificities include multiple HLA-D determinants on a single haplotype, Transplant. Proc. 10: 781.PubMedGoogle Scholar
  28. Giles, R., Nunez, G., Hurley, C., Nunez-Roldan, A., Winchester, R., Stastny, P., and Capra, J. D., 1983, Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB-3 like specificity, J. Exp. Med. 157: 1461–1470.PubMedCrossRefGoogle Scholar
  29. Gladstone, P., and Pious, D., 1980, Identification of a transacting function regulating HLA-DR expression in a DR-negative cell variant, Somat. Cell Genet. 6: 285–298.PubMedCrossRefGoogle Scholar
  30. Gonwa, T., Peterlin, B. M., and Stobo, J. D., 1983a, Human Ir genes: Structure and function, Adv. Immunol. 34: 71–96.PubMedCrossRefGoogle Scholar
  31. Gonwa, T., Picker, L., Raff, H., Goyert, S., Silver, J., and Stobo, I., 1983b, Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an la determinant distinct from HLA- DR, J. Immunol. 130: 706–711.PubMedGoogle Scholar
  32. Goyert, S. M., and Silver, J., 1983, Further characterization of HLA-DS molecules: Implications for studies assessing the role of human la molecules in cell interactions and disease susceptibility, Proc. Natl. Acad. Sci. U.S.A. 80: 5719–5723.PubMedCrossRefGoogle Scholar
  33. Goyert, S. M., Shively, J. E., and Silver, J., 1982, Biochemical characterization of a second family of human la molecules, HLA-DS, equivalent to murine I-A subregion molecules, J. Exp. Med. 156: 550–556.PubMedCrossRefGoogle Scholar
  34. Goyert, S. M., Moriuchi, J., Winchester, R. J., and Silver, J., 1983, HLA-DS molecules and their relation to supertypic specificities, Hum. Immunol. 8: 53–63.PubMedCrossRefGoogle Scholar
  35. Groner, J. P., Watson, A. J., and Bach, F. H., 1983, Dw/LD-related molecular polymorphism of DR4 β chains, J. Exp. Med. 157: 1687–1691.PubMedCrossRefGoogle Scholar
  36. Greenberg, L. J., Gray, E. D., and Yunis, E. J., 1975, Association of HLA-5 and immune responsiveness in vitro to streptococcal antigens, J. Exp. Med. 141: 935–943.PubMedCrossRefGoogle Scholar
  37. Greenberg, L. J., Bradley, P. W., Chopyk, R. L., and Lalovel, J. M., 1980, Immunogenetics of response to a purified antigen from group A streptococci, II Linkage of reponse to HLA, Immunogenetics 11: 161–167.PubMedCrossRefGoogle Scholar
  38. Haverkorn, M. J., Hofman, B., Masurel, N., and van Rood, J. J., 1975, HLA-linked genetic control of immune response in man, Transplant Rev. 22: 120–124.PubMedGoogle Scholar
  39. Hood, L., Steinmetz, M., and Malissen, B., 1983, Genes of the major histocompatibility complex of the mouse, Annu. Rev. Immunol. 1: 529–568.PubMedCrossRefGoogle Scholar
  40. Hsu, S. H., Chan, M. M., and Bias, W. B., 1981, Genetic control of major histocompatibility complex-linked immune responses to synthetic polypeptides in man, Proc. Natl. Acad. Sci. U.S.A. 78: 440–444.PubMedCrossRefGoogle Scholar
  41. Hurley, C. K., Shaw, S., Nadler, L., Schlossman, S., and Capra, J. D., 1982, Alpha and beta chains of SB and DR antigens are structurally distinct, J. Exp. Med. 156: 1557–1562.PubMedCrossRefGoogle Scholar
  42. Jacobson, S., Nepom, G. T., Richert, J. R., Biddison, W. E., and McFarland, H. F., 1985, Identification of a specific HLA DR2 la molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones, J. Exp. Med. 161: 263–268.PubMedCrossRefGoogle Scholar
  43. Jones, P. P., Murphy, D. B., and McDevitt, H. O., 1978, Two gene control of the expression of a murine la antigen, J. Exp. Med. 148: 925–939.PubMedCrossRefGoogle Scholar
  44. Karr, R. W., Kannapell, C., Stein, J., Fuller, T., Duquesnoy, R., Rodey, G., Mann, D., Gebel, H., and Schwartz, B. D., 1982a, Demonstration of a third structurally distinct human la beta chain by two- dimensional gel electrophoresis, J. Exp. Med. 156: 652–657.CrossRefGoogle Scholar
  45. Karr, R. W., Kannapell, C., Stein, J., Gebel, H., Mann, D., Duquesnoy, R., Fuller, T., Rodey, G., and Schwartz, B. D., 1982b, Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5, J. Immunol. 128: 1809–1818.Google Scholar
  46. Karr, R., Kannapell, C., Zangara, R., Goyert, S., Silver, J., and Schwartz, B. D., 1983, An HLA-DR5 homozygous cell line expresses two DS (I-A-like) molecules, J. Exp. Med. 158: 1374–1379.PubMedCrossRefGoogle Scholar
  47. Kato, S., Kimura, M., Takahura, I., Sakakibara, T., Inoue, H., and Tsuji, K., 1978, Possible associations between HLA antigens and the immune responsiveness to attenuated rubella vaccine, Tissue Antigens 11: 475–478.PubMedCrossRefGoogle Scholar
  48. Kaufman, J. F., and Strominger, J. L., 1982, HLA-DR light chain has a polymorphic N-terminal region and a conserved lg-like C-terminal region, Nature 297: 694–697.PubMedCrossRefGoogle Scholar
  49. Klein, J., and Figueroa, F., 1981, Polymorphism of the mouse H-2 loci, Immunol. Rev. 60: 23–51.PubMedCrossRefGoogle Scholar
  50. Kratzin, H., Yang, C., Gotz, H., Thinnes, F. P., Kruse, T., Egert, G., Pauly, E., Kolbel, S., Wernet, P., and Hilschmann, N., 1983, Heterogeneity of class II histocompatibility antigens isolated from a human lymphoblastoid B cell line homozygous at the HLA Loci, Hum. Immunol. 8: 65–73.PubMedCrossRefGoogle Scholar
  51. Kvist, S., Wiman, K., Claesson, L., Peterson, P. A., and Dobberstein, B., 1982, Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens, Cell 29: 61–69.PubMedCrossRefGoogle Scholar
  52. LaFuse, W., McCormick, J., Corser, P., and David, C., 1980a, Gene complementations to generate la antigens (Ia.23) on hybrid molecules, Transplantation 30: 341–346.CrossRefGoogle Scholar
  53. LaFuse, W. P., McCormick, J. F., and David, C. S., 1980b, Serological and biochemical identification of hybrid la antigens, J. Exp. Med. 151: 709–715.CrossRefGoogle Scholar
  54. Larhammar, D., Schenning, L., Gustafsson, K., Wiman, K., Claesson, L., Rask, L., and Peterson, P., 1982, Complete amino acid sequence of an HLA-DR antigen-like p chain as predicted from the nucleotide sequence; similarities with immunoglobulins and HLA-A-B and -C antigens, Proc. Natl. Acad. Sci. U.S.A. 79: 3687–3691.PubMedCrossRefGoogle Scholar
  55. Larhammer, D., Andersson, A., Andersson, M., Bill, P., Bohme, J., Claesson, L., Denaro, M., Emmoth, E., Gustafsson, K., Hammarling, V., Heldin, E., Hyldig-Nielsen, J. J., Lind, P., Schenning, L., Servenius, B., Widmark, E., Rask, L., and Peterson, P. A., 1983, Molecular analysis of human class II transplantation antigens and their genes, Hum. Immunol. 8: 95–103.CrossRefGoogle Scholar
  56. Long, E. Gorski, J., Rollini, P., Wake, C. T., Strubin, M., Raborndin-Combe, C., and Mach, B., 1983, Molecular Analysis of the genes for human class II antigens of the major histocompatibility complex, Hum. Immunol. 8: 113–121.PubMedCrossRefGoogle Scholar
  57. Maeda, H., and Hirata, R., 1984, Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA- DR4 homozygous B cell lines, J. Immunol. 132: 574–577.PubMedGoogle Scholar
  58. Markert, M. L., and Cresswell, P., 1980, Polymorphism of human B-cell alloantigens: Evidence for three loci within the HLA system, Proc. Natl. Acad. Sci. U.S.A. 77: 6101–6104.PubMedCrossRefGoogle Scholar
  59. McDevitt, H. O., 1980, Regulation of the immune response by the major histocompatibility system, N. Engl. J. Med. 303: 1514–1517.PubMedCrossRefGoogle Scholar
  60. Mickelson, E. M., Nisperos, B., Layrisse, Z., Kim, S. J., Thomas, E. D., and Hansen, J. A., 1983, Analysis of the HLA-DRw8 haplotype: Recognition by HTC typing of three distinct antigen complexes in Caucasians, Native Americans, and Orientals, Immunogenetics 17: 399–410.PubMedCrossRefGoogle Scholar
  61. Neiderhuber, J. E., and Frelinger, J. A., 1976, Expression of la antigens on T and B cells and their relationship to immune-response functions, Transplant. Rev. 30: 101–130.Google Scholar
  62. Nepom, B. S., Nepom, G. T., Mickelson, E., Antonelli, P., and Hansen, J. A., 1983, Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: Correlation between p chain diversity and HLA-D, Proc. Natl. Acad. Sci. U.S.A. 80: 6962–6966.PubMedCrossRefGoogle Scholar
  63. Nepom, G. T., Nepom, B. S., Antonelli, P., Mickelson, E., Silver, J., Goyert, S. M., and Hansen, J. A., 1984a, The HLA-DR4 family of haplotypes consist of a series of distinct DR and DS molecules, J. Exp. Med. 59: 394–404.CrossRefGoogle Scholar
  64. Nepom, G. T., Nepom, B., Wilson, M., Mickelson, E., Antonelli, P., and Hansen, J. A., 1984b, Multiple “la-like” molecules characterize HLA-DR2-associated haplotypes which differ in HLA-D, Hum. Immunol. 10: 143–151.CrossRefGoogle Scholar
  65. Nepom, B. S., Nepom, G. T., Mickelson, E., Schaller, J. A., Antonelli, P., and Hansen, J. A., 1984c, Specific HLA-DR4-associated histocompatibility molecules characterize patients with juvenile rheumatoid arthritis, J. Clin. Invest. 74: 287–291.CrossRefGoogle Scholar
  66. Newman, R., Delia, D., Greaves, M., Navarrete, C., Fainboim, L., and Festenstein, H., 1983, Differential expression of HLA-DR and DR-linked determinants on human leukemias and lymphoid cells, Eur. J. Immunol. 13: 172–176.PubMedCrossRefGoogle Scholar
  67. Nishimura, Y., and Sasazuki, T., 1982, HLA-linked immune suppression gene for streptococcal cell wall antigen, Nature 302: 67–69.CrossRefGoogle Scholar
  68. Nose, Y., Sato, K,, Nakagawa, N., Kondoh, K., Inouye, H., and Tsuji, K., 1982, HLA-D clusters associated with DR4 in the Japanese population, Hum. Immunol. 5: 199–203.PubMedCrossRefGoogle Scholar
  69. O’Farrell, P. Z., Goodman, H. M., and O’Farrell, P. H., 1977, High resolution two-dimensional electrophoresis of basic as well as acidic proteins, Cell 12: 1133–1142.PubMedCrossRefGoogle Scholar
  70. Payne, R., and Rolfs, M. R., 1958, Fetomaternal leukocyte incompatibility, J. Clin. Invest. 37: 1756–1763.PubMedCrossRefGoogle Scholar
  71. Reinsmoen, N. L., and Bach, F. H., 1982, Five HLA-D clusters associated with HLA-DR4, Hum. Immunol. 4: 249–258.PubMedCrossRefGoogle Scholar
  72. Rosenthal, A. S., 1978, Determinant selection and macrophage function in genetic control of the immune response, Immunol. Rev. 40: 136–152.PubMedCrossRefGoogle Scholar
  73. Sasazuki, T., Kohno, Y., Iwamoto, I., Tanimura, M., and Naito, S., 1978b, Association between and HLA haplotype and low responsiveness to tetanus toxoid in man, Nature 272: 359–360.PubMedCrossRefGoogle Scholar
  74. Sasazuki, T., Ohta, N., Isohisa, I., Numano, F., and Maezawa, H., 1979a, Association between Takayasu disease and HLA-DHO, Tissue Antigens 14: 177–178.PubMedCrossRefGoogle Scholar
  75. Sasazuki, T., Hayase, R., Iwamoto, I., and Tsuchida, H., 1979b, HLA and acute poststreptococcal glomerulonephritis, N. Engl. J. Med. 301: 1184–1185.PubMedGoogle Scholar
  76. Sasazuki, T., Ohta, N., Kaneoka, R., and Kojima, S., 1980a, Association between and HLA haplotype and low responsiveness to schistosomal worm antigen in man, J. Exp. Med. 152: 314s–318s.Google Scholar
  77. Sasazuki, T., Kaneoka, H., Nishimura, Y., Kaneoka, R., Hayama, M., and Okhuni, H., 1980b, An HLA- linked immune suppression gene in man, J. Exp. Med. 152: 297s–313s.Google Scholar
  78. Sasazuki, T., Nishimura, Y., Muto, M., and Ohta, N., 1983, HLA-linked genes controlling immune response and disease susceptibility, Immunol. Rev. 70: 51–75.PubMedCrossRefGoogle Scholar
  79. Shackelford, D. A., Kaufman, J. F., Korman, A. J., and Strominger, J. L., 1982, HLA-DR antigens: Structure, separation of subpopulations, gene cloning and function, Immunol. Rev. 66: 133–187.PubMedCrossRefGoogle Scholar
  80. Shackelford, D. A., Lampson, L. A., and Strominger, J. A., 1983, Separation of three class II antigens from a homozygous human B cell line, J. Immunol. 130: 289–296.PubMedGoogle Scholar
  81. Shipp, M., Schwartz, B., Kannapell, C., Griffith, R., Scott, M., Ahmed, P., David, J. M., and Nahm, M., 1983, A unique DR-related B cell differentiation antigen, J. Immunol. 131: 2458–2467.PubMedGoogle Scholar
  82. Snell, G. D., 1981, Studies in histocompatibility, Science 213: 172–178.PubMedCrossRefGoogle Scholar
  83. Spencer, M. J., Cherry, J. D., and Terasaki, P. I., 1976, HLA antigens and antibody response after influenza A vaccination. Decreased response associated with HLA type W16, N. Engl. J. Med. 294: 13–16.PubMedCrossRefGoogle Scholar
  84. Springer, T. A., Kaufman, J. F., Siddoway, L. A., Giphart, M., Mann, D. L., Terhorst, C., and Strominger, J. L., 1977, Chemical and immunological characterization of HL-A-linked B-lymphocyte alloantigens, Cold Spring Harbor Symp. Quant. Biol. 41: 387–396.Google Scholar
  85. Suciu-Foca, N., Godfrey, M., Khan, R., Woodward, K., Rohowsky, C., Reed, E., Hardy, M., andReemtsma, K., 1981, New HLA-D alleles associated with DR1 and DR2, Tissue Antigens 17: 294–302.PubMedCrossRefGoogle Scholar
  86. Svejgaard, A., and Ryder, L. P., 1981, HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus, Ann. Hum. Genet. 45: 293.PubMedCrossRefGoogle Scholar
  87. Terasaki, P. I., ed., 1980, Histocompatibility Testing 1980, University of California, Los Angeles Press, Los Angeles.Google Scholar
  88. Torok-Storb, B., Nepom, G. T., Nepom, B. S., and Hansen, J. A., 1983, HLA-DR antigens on lymphoid cells differ from those on myeloid cells, Nature 305: 541–543.PubMedCrossRefGoogle Scholar
  89. van Rood, J. J., Eernisse, J. G., and Van Leeuwen, A., 1958, Leucocyte antibodies in sera from pregnant women, Nature 181: 1735–1736.CrossRefGoogle Scholar
  90. de Vries, R., Kreeftenberg, H., Loggen, H., and van Rood, J. J., 1977, In vitro immune responsiveness to vaccinia virus and HLA, N. Engl. J. Med. 297: 692–696.PubMedCrossRefGoogle Scholar
  91. Wake, C. T., Long, E. O., and Mach, B., 1982, Allelic polymorphism and complexity of the genes for HLA- DR p chains; direct analysis by DNA-DNA hybridization, Nature 300: 372–373.PubMedCrossRefGoogle Scholar
  92. Walker, L. E., Hewick, R., Hunkapiller, M. W., Hood, L. E., Dreyer, W. J., and Reisfeld, R. A., 1983, N- Terminal amino acid sequences of the a and β chains of HLA-DR 1 and HLA-DR2 antigens, Biochemistry 22: 185–188.PubMedCrossRefGoogle Scholar
  93. Wang, C., Al-Katib, A., Lane, C., Koziner, B., and Fu, S. M., 1983, Induction of HLA-DC/DS (Leu 10) antigen expression by human precursor B cell lines, J. Exp. Med. 158: 1757–1762.PubMedCrossRefGoogle Scholar
  94. Winchester, R. J., and Kunkel, H. G., 1979, The human la system, Adv. Immunol. 28: 221–292.PubMedCrossRefGoogle Scholar
  95. Yunis, E. J., and Amos, D. B., 1971, Three closely linked genetic systems relevant to transplantation, Proc. Natl. Acad. Sci. U.S.A. 68: 3031–3035.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Gerald T. Nepom
    • 1
  • John A. Hansen
    • 2
  1. 1.Genetic Systems CorporationUniversity of Washington School of MedicineSeattleUSA
  2. 2.The Fred Hutchinson Cancer Research Center, the Puget Sound Blood CenterUniversity of Washington School of MedicineSeattleUSA

Personalised recommendations